Products - Osteoporosis | Topic | NICE

Showing 2 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Romosozumab for treating severe osteoporosis (TA791)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
25 May 2022
Abaloparatide for treating idiopathic or hypogonadal osteoporosis in men [ID4059]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC